ksb-d02-k0005

name	KSB-D02-K0005
description	Type E Reactions: End-of-treatment withdrawal effects...
version	1.0.0
domain	D02
domain_name	Clinical Aspects of ADRs
type	Knowledge
proficiency_level	L1
bloom_level	understand
triggers	["explain type e reactions","what is type e reactions","explain type e reactions"]
epa_mapping	EPA-01, EPA-02, EPA-05
cpa_mapping	CPA-01, CPA-02
regulatory_refs	ICH-E2A, FDA-GUID-001

KSB-D02-K0005: Type E Reactions

Overview

Domain: D02 - Clinical Aspects of ADRs Type: Knowledge Proficiency Level: L1 (Novice - Direct supervision required) Bloom Level: Understand

Description

End-of-treatment withdrawal effects

Context

• Major Section: ADR Classification Systems
• Section: ADR Classification Systems

EPA Mapping

• EPA-01:3001-3003
• EPA-02:3004-3005
• EPA-05:3011-3012

CPA Pathway

• CPA-01, CPA-02

Regulatory References

• ICH-E2A
• FDA-GUID-001

Instructions

When this skill is activated, Claude should:

1. Demonstrate L1 proficiency in type e reactions
2. Apply understand level cognitive skills to explain the topic
3. Reference relevant regulatory guidance (ICH-E2A, FDA-GUID-001)
4. Connect to related EPAs: EPA-01, EPA-02, EPA-05

Key Competencies

• End-of-treatment withdrawal effects

Assessment Criteria

• Can explain core concepts independently
• Demonstrates understanding of regulatory context
• Applies knowledge appropriately to PV scenarios

Related Skills

• Other D02 skills in ADR Classification Systems
• Cross-domain integrations per DAG architecture

---

Generated from PV KSB Framework v1.0 | 2025-12-31